Literature DB >> 17183004

Use of statins and outcome of BCG treatment for bladder cancer.

Paul Hoffmann, Thierry Roumeguère, Claude Schulman, Roland van Velthoven.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17183004     DOI： 10.1056/NEJMc062714

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  20 in total

1.  Effects of statins on the risk of hepatocellular carcinoma.

Authors:  Pejman G Mansourian; Masato Yoneda; M Krishna Rao; Fernando J Martinez; Emmanuel Thomas; Eugene R Schiff
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-07

2.  Simvastatin enhances irinotecan-induced apoptosis in human non-small cell lung cancer cells by inhibition of proteasome activity.

Authors:  In Hae Park; Jin Young Kim; Ji Young Choi; Ji-Youn Han
Journal:  Invest New Drugs       Date:  2010-05-14       Impact factor: 3.850

Review 3.  Expert consensus document: Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer.

Authors:  Ashish M Kamat; Thomas W Flaig; H Barton Grossman; Badrinath Konety; Donald Lamm; Michael A O'Donnell; Edward Uchio; Jason A Efstathiou; John A Taylor
Journal:  Nat Rev Urol       Date:  2015-03-24       Impact factor: 14.432

4.  Anti-inflammatory use may not negatively impact oncologic outcomes following intravesical BCG for high-grade non-muscle-invasive bladder cancer.

Authors:  Nirmish Singla; Ahmed Q Haddad; Niccolo M Passoni; Matthew Meissner; Yair Lotan
Journal:  World J Urol       Date:  2016-05-18       Impact factor: 4.226

5.  Reversal of chemoresistance and enhancement of apoptosis by statins through down-regulation of the NF-kappaB pathway.

Authors:  Kwang Seok Ahn; Gautam Sethi; Bharat B Aggarwal
Journal:  Biochem Pharmacol       Date:  2007-10-16       Impact factor: 5.858

6.  Statin use and the risk of cholecystectomy in women.

Authors:  Chung-Jyi Tsai; Michael F Leitzmann; Walter C Willett; Edward L Giovannucci
Journal:  Gastroenterology       Date:  2009-01-24       Impact factor: 22.682

7.  Reply to Hu et al: Could there be detrimental effects of statin adjunctive TB therapy on immune responses?

Authors:  Noton K Dutta; Petros C Karakousis
Journal:  J Infect Dis       Date:  2020-06-29       Impact factor: 7.759

8.  Lifestyle and Non-muscle Invasive Bladder Cancer Recurrence, Progression, and Mortality: Available Research and Future Directions.

Authors:  Kyle B Zuniga; Rebecca E Graff; David B Feiger; Maxwell V Meng; Sima P Porten; Stacey A Kenfield
Journal:  Bladder Cancer       Date:  2020-03-28

9.  Do statins prevent or promote cancer?

Authors:  Mark R Goldstein; Luca Mascitelli; Francesca Pezzetta
Journal:  Curr Oncol       Date:  2008-04       Impact factor: 3.677

10.  Effects of Fibrin Clot Inhibitors and Statins on the Intravesical Bacille Calmette-Guérin Therapy for Bladder Cancer: A Systematic Review and Meta-Analysis.

Authors:  Zhiyong Cai; Jiao Hu; Belaydi Othmane; Huihuang Li; Dongxu Qiu; Zhenglin Yi; Jinbo Chen; Xiongbing Zu
Journal:  Front Oncol       Date:  2021-06-21       Impact factor: 6.244
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.